Ariel Hurley - 17 May 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Principal Accounting Officer
Signature
/s/ Ariel Hurley
Issuer symbol
BPMC
Transactions as of
17 May 2021
Net transactions value
-$283,196
Form type
4
Filing time
19 May 2021, 16:11:31 UTC
Next filing
03 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $5,720 +650 +5.5% $8.80* 12,452 17 May 2021 Direct F1
transaction BPMC Common Stock Options Exercise $1,309 +700 +5.6% $1.87* 13,152 17 May 2021 Direct F1
transaction BPMC Common Stock Sale $290,225 -3,055 -23% $95.00 10,097 17 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -650 -24% $0.000000 2,014 17 May 2021 Common Stock 650 $8.80 Direct F1, F2
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -700 -12% $0.000000 5,054 17 May 2021 Common Stock 700 $1.87 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on March 12, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 This option was granted on February 10, 2015 and is fully vested as of the date hereof.
F3 This option was granted on October 8, 2014 and is fully vested as of the date hereof.